Drug firm Unichem Laboratories today said it has received the US health regulator's approval to sell its generic Bisoprolol and Hydrochlorothiazide tablets, used for treatment of heart disease, in the US market.
The company's Abbreviated New Drug Application (ANDA) for marketing Bisoprolol and Hydrochlorothiazide tablets has been approved by the US Food and Drug Administration (USFDA), Unichem Labs said in a statement.
"The product will be immediately commercialised from Unichem's Goa plant," the company said.
Shares of Unichem Laboratories today closed at Rs 443.90 on the BSE, up 2.02 per cent from the previous close.
